| ADTX 0.01 127.27% | GDC 0.0181 -15.02% | SOXS 3.59 -19.51% | GPUS 0.359 -9.78% | SRXH 0.1245 -37.59% | BITO 8.56 -1.95% | TZA 4.02 -5.85% | SPCX 185 -3.56% | MRVL 310.58 7.27% | CDT 1.02 47.19% | NVDA 210.69 2.95% | INTC 133.99 10.64% | WKSP 0.7379 23.33% | INLF 0.1566 -64.20% | NOK 13.49 -2.46% | AAL 15.99 3.70% | AZTR 0.1717 -15.42% | CAST 8.07 56.70% | CRVO 4.24 11.29% | NFLX 77.38 0.55% | AMC 2.83 6.39% | QS 8.04 16.52% | FLEX 147.61 3.13% | GRAB 3.57 3.48% | SOFI 17.91 2.81% | YYGH 0.0803 -37.70% | AAPL 298.01 0.70% | ATPC 3.88 42.12% | RKLB 107.24 -0.69% | BAC 56.2 -0.58% | LNKS 2.68 67.50% | SMCI 30.66 10.37% | PFE 25.22 -2.70% | SPY 746.74 0.78% | RIG 5.31 -4.84% | AMZN 244.39 2.90% | PLUG 2.85 7.55% | CRWV 117.95 2.38% | TSLL 13.16 1.86% | ONDS 9.27 1.64% | CMCSA 22.43 -1.15% | MU 1133.99 8.70% | TQQQ 82.87 6.87% | BFLY 8.9 55.87% | NVD 4.75 -5.57% | SQQQ 36.75 -7.01% | MSFT 379.4 0.13% | CTSH 43.7 -10.49% | WPRT 2.26 21.51% | T 22.01 -1.92%

Insider Selling at Arteris, Inc. (NASDAQ:AIP) Raises Questions

Arteris, Inc. (NASDAQ:AIP) operates in the semiconductor industry, providing network-on-chip (NoC) interconnect IP solutions. These solutions are crucial for the design and development of complex system-on-chip (SoC) architectures. Arteris competes with other semiconductor companies that offer similar IP solutions, such as Synopsys and Cadence Design Systems.

On March 4, 2026, Raza Saiyed Atiq, a director at Arteris, executed a sale of 3,690 shares of the company's common stock at approximately $17.02 per share. This transaction follows a series of sales by Raza, including a significant sale of 73,610 shares on February 26th at an average price of $17.14 per share, totaling around $1.26 million. These sales have reduced Raza's holdings in the company by 12.58%.

Despite these sales, Raza still holds a substantial number of shares, with 390,000 shares remaining after the March 4th transaction. Prior to this, Raza had 511,483 shares valued at approximately $8.77 million. The recent sales reflect a strategic reduction in Raza's position, possibly influenced by the company's current financial metrics.

Arteris' stock opened at $16.99 following these transactions, showing a 1.3% decrease. The stock has fluctuated between a 12-month low of $5.46 and a high of $17.14. The company's financial metrics reveal challenges, with a negative price-to-earnings (P/E) ratio of -20.71, indicating negative earnings. The price-to-sales ratio is 10.60, and the enterprise value to sales ratio is 10.25, suggesting a high valuation relative to sales.

The company's financial health is further highlighted by a negative earnings yield of -4.83% and a debt-to-equity ratio of -0.62, indicating more equity than debt, which is unusual and may suggest negative equity. The current ratio of 1.13 suggests a reasonable level of short-term liquidity, with current assets slightly exceeding current liabilities. These metrics provide insight into the company's financial position amidst the recent insider selling activity.

Published on: March 5, 2026